Premaith Health embarking on product knowledge tour
International molecular diagnostics group Premaitha Health announced on Monday that it would be attending a series of “key” international fetal medicine and OB/GYN events during March to broaden awareness of its IONA test product.
FTSE AIM All-Share
745.67
17:08 19/04/24
Pharmaceuticals & Biotechnology
21,247.91
17:09 19/04/24
Yourgene Health
0.52p
17:15 07/09/23
The AIM-traded company said the events would include the Royal College of Obstetricians and Gynaecologists World Congress 2017 in Cape Town on 20-22 March, Forum Labo in Paris on 28-30 March, the British Maternal and Fetal Medicine Society 19th Annual Conference in Amsterdam on 30-31 March, and ASPIRE 2017 in Kuala Lumpur on 30 March-2 April.
“Raising awareness of the superiority of the IONA test among the international OB/GYN community is key to helping drive samples to our customers' laboratories,” said Premaith CEO Stephen Little.
“March is expected to be a very busy month in the ongoing educational programme,” Dr Little added.